S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia

NCT00003416 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: recombinant interferon alfa
DRUG: dexamethasone
DRUG: melphalan
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]